WW International announced that it would acquire digital health company Sequence for a net consideration of about $106 million, as it looks to enter the increasingly popular obesity drug market.
WW International announced that it would acquire digital health company Sequence for a net consideration of about $106 million, as it looks to enter the increasingly popular obesity drug market.
Share this Article
Recommended